NCT03729869View on ClinicalTrials.gov

Impact of Progesterone on Stress Reactivity and Cannabis Use

PHASE2CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

November 9, 2022

Study Completion Date

November 9, 2022

Conditions
Cannabis Use
Interventions
DRUG

Progesterone

200 mg of exogenous progesterone twice a day

DRUG

Placebo

One dose of matched placebo twice a day.

Trial Locations (1)

29403

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Medical University of South Carolina

OTHER

NCT03729869 - Impact of Progesterone on Stress Reactivity and Cannabis Use | Biotech Hunter | Biotech Hunter